ERBB2 and breast cancer: In addition to the number, the phenotype of the CTC was evaluated in the same study, including the expression of human epidermal growth factor receptor 2 (HER2), along with other potential markers for the identification and characterization of CTC for breast cancer brain metastases [7,8].